Diligence memo · auto-generated · as of July 2, 2026
Recreo Pharmaceuticals Llc
Recreo Pharmaceuticals Llc has raised $3.2M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Recreo Pharmaceuticals Llc operates in Biotech / Pharma, based in SUPERIOR.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Recreo Pharmaceuticals Llc has raised $3.2M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2017-11-01.
Most recent recorded round closed around 2017-11-01.
Valuation (modeled)modeled
Provath models Recreo Pharmaceuticals Llc at approximately $123M (range $2.2M–$969M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 20 months.
Last raise 8.7 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 12.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 43% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 74% of those peers.
Closest niche peers: Vivacelle Bio, Inc., ClearLight Biotechnologies, LLC, Base Pair Biotechnologies, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.